It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
An End-to-End Literature Search Solution for Medical Writers | Medical Literature Search
Cactus Life Sciences offers an easy-to-use AI-based literature search tool for medical writers in pharma...
17th Virtual Annual Meeting of ISMPP: A Summarized Report
Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...
How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead
The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Preprints, MedRxiv, and Pharma – An Overview
Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...
To Preprint or Not to Preprint: Debate at the 17th Annual ISMPP Meeting
The Covid-19 pandemic has brought with it a deluge of preprints. While timely sharing of...
Strategic Publication Planning: Infographic for Medical Affairs
Here's a quick and easy-to-follow guide on for medical affairs teams on the what, how...